People queue to be tested for COVID-19 in Times Square, as the Omicron coronavirus variant continues to spread in Manhattan, New York City, U.S., December 20, 2021. REUTERS/Andrew Kelly/File PhotoRegister now for FREE unlimited access to Reuters.comWASHINGTON, May 18 (Reuters) - Health officials are considering extending the eligibility for a second COVID-19 vaccine booster dose…
Health officials are considering extending the eligibility for a second COVID-19 vaccine booster dose to people under 50 amid a steady rise in cases, with the United States seeing a threefold increase over the past month.
The U.S. Food and Drug Administration had in late March authorized a second booster dose of the Moderna (MRNA.O) and Pfizer (PFE.N)/BioNTech SE (22UAy.DE) vaccines for people aged 50 and older, citing data showing waning immunity and the risks posed by Omicron variants of the virus.
“With regard to a fourth dose for those under the age of 50, that is going to require action from the FDA, and we’re in conversations there,” U.S. Centers for Disease Control and Prevention Director Rochelle Walenksy said on Wednesday.
Read Full Story
Reuters Rating
Discover more from News Facts Network
Subscribe to get the latest posts sent to your email.
